Contract 75F40122P00547
Kemp Proteins, Llc · Department Of Health And Human Services · September 26, 2022
Kemp Proteins, Llc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 26, 2022 for $34,000 of work in biological product (except diagnostic) manufacturing. Performance is in Beltsville, MD. It was awarded under a small business set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 11, 2023. If all options are exercised, the contract could reach $89,000.
Contract details
- PIID
- 75F40122P00547
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
- Place of performance
- Beltsville, MD
- First action
- September 26, 2022
- Latest action
- August 11, 2023
Description
MONOCLONAL ANTIBODY PRODUCTION
Modification timeline
-
August 11, 2023Mod P00001$17.3K
-
September 26, 2022Base award$16.8K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40122P00547?
Contract 75F40122P00547 is a federal contract awarded to Kemp Proteins, Llc by Department Of Health And Human Services on September 26, 2022 for $34,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75F40122P00547?
Kemp Proteins, Llc won contract 75F40122P00547 from Department Of Health And Human Services.
How much is contract 75F40122P00547 worth?
Contract 75F40122P00547 has obligated $34,000 to date, with a total potential value of $89,000 if all options are exercised.